What is the intrinsic value of FGEN?
As of 2026-01-07, the Intrinsic Value of FibroGen Inc (FGEN) is
266.24 USD. This FGEN valuation is based on the model Peter Lynch Fair Value.
With the current market price of 9.02 USD, the upside of FibroGen Inc is
2,851.66%.
Is FGEN undervalued or overvalued?
Based on its market price of 9.02 USD and our intrinsic valuation, FibroGen Inc (FGEN) is undervalued by 2,851.66%.
266.24 USD
Intrinsic Value
FGEN Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
(1,078.45) - (11.38) |
(42.32) |
-569.2% |
| DCF (Growth 10y) |
(13.00) - (998.26) |
(42.70) |
-573.4% |
| DCF (EBITDA 5y) |
(37.44) - (85.51) |
(1,234.50) |
-123450.0% |
| DCF (EBITDA 10y) |
(24.69) - (102.00) |
(1,234.50) |
-123450.0% |
| Fair Value |
266.24 - 266.24 |
266.24 |
2,851.66% |
| P/E |
1,028.75 - 1,739.08 |
1,299.25 |
14304.1% |
| EV/EBITDA |
41.76 - 73.60 |
51.54 |
471.4% |
| EPV |
(254.71) - (1,005.41) |
(630.06) |
-7085.1% |
| DDM - Stable |
415.77 - 2,033.59 |
1,224.68 |
13477.4% |
| DDM - Multi |
(52.92) - (208.76) |
(85.28) |
-1045.5% |
FGEN Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
36.53 |
| Beta |
0.56 |
| Outstanding shares (mil) |
4.05 |
| Enterprise Value (mil) |
-61.97 |
| Market risk premium |
4.60% |
| Cost of Equity |
9.66% |
| Cost of Debt |
14.32% |
| WACC |
12.95% |